Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.75 USD | -6.61% | -3.72% | -28.86% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.86% | 2.89B | |
-3.08% | 104B | |
+0.18% | 97.42B | |
+1.02% | 22.2B | |
-18.21% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.18% | 15.06B | |
+3.50% | 13.98B | |
+29.20% | 11.66B |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Arrowhead Pharmaceuticals : Says Interim Phase 1 Data Show Potentially Early Signs of Efficacy of ARO-HIF2 in Renal Cell Carcinoma Patients